| Dr Yinaris Beatriz Vazquez Torres, MD | |
|
# 56 Cruz Ortiz Stella, Humacao, PR 00791 | |
| (787) 852-5662 | |
| Not Available |
| Full Name | Dr Yinaris Beatriz Vazquez Torres |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Experience | 21 Years |
| Location | # 56 Cruz Ortiz Stella, Humacao, Puerto Rico |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275514812 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 15491 (Puerto Rico) | Primary |
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
While researchers have learned in the last decade that combining chemotherapy with radiation is better than radiation alone for treating non-small cell lung cancer patients with locally advanced disease - cancer confined to the lungs - finding the right combination of drugs - and the best timing of treatment - has been tricky.
From the bark of a puppy to the patter of rain against the window, our brains receive countless signals every second. Most of the time, we tune out inconsequential cues-the buzz of a fly, the soft rustle of leaves in the tree-and pay attention to important ones-the sound of a car horn, a bang on the door.
Protalex, Inc., a clinical stage biopharmaceutical company engaged in developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, today announced the dosing of the first patient in a multicenter Phase 1b clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA). The study is being conducted in South Africa.
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
The latest issue of The Journal of Gerontology: Medical Sciences (Vol. 63, No. 3) features a special section devoted to the phenomenon of multidimensional geriatric assessment - an interdisciplinary diagnostic process to determine the medical, psychological, and functional status of at-risk and frail elderly patients in order to develop a coordinated, integrated plan for treatment and long-term follow-up.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yinaris Beatriz Vazquez Torres, MD #186 Calle Cruz Ortiz Stella, Humacao, PR 00791 Ph: (787) 852-5662 | Dr Yinaris Beatriz Vazquez Torres, MD # 56 Cruz Ortiz Stella, Humacao, PR 00791 Ph: (787) 852-5662 |
News Archive
While researchers have learned in the last decade that combining chemotherapy with radiation is better than radiation alone for treating non-small cell lung cancer patients with locally advanced disease - cancer confined to the lungs - finding the right combination of drugs - and the best timing of treatment - has been tricky.
From the bark of a puppy to the patter of rain against the window, our brains receive countless signals every second. Most of the time, we tune out inconsequential cues-the buzz of a fly, the soft rustle of leaves in the tree-and pay attention to important ones-the sound of a car horn, a bang on the door.
Protalex, Inc., a clinical stage biopharmaceutical company engaged in developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, today announced the dosing of the first patient in a multicenter Phase 1b clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA). The study is being conducted in South Africa.
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
The latest issue of The Journal of Gerontology: Medical Sciences (Vol. 63, No. 3) features a special section devoted to the phenomenon of multidimensional geriatric assessment - an interdisciplinary diagnostic process to determine the medical, psychological, and functional status of at-risk and frail elderly patients in order to develop a coordinated, integrated plan for treatment and long-term follow-up.
› Verified 5 days ago
Yanitzmary Rodriguez Santos, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 3 Calle Font Martelo E, Humacao, PR 00791 Phone: 787-656-2424 Fax: 787-653-3553 | |
Angel Miguel Ortiz Ortega, MD General Practice Medicare: Medicare Enrolled Practice Location: Av Font Martelo, Humacao, PR 00791 Phone: 787-534-3789 | |
Dr. Marangely Rodriguez, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: Ave Font Martelo #303, Humacao, PR 00791 Phone: 787-931-7555 Fax: 407-386-7022 | |
Josean Sepulveda, MD General Practice Medicare: Medicare Enrolled Practice Location: 355 Calle Font Martelo, Humacao, PR 00791 Phone: 787-852-0768 | |
Evelyn Gomez-garcia, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 355 Ave Font Martelo, Humacao, PR 00791 Phone: 787-852-0768 | |
Dr. Juan Manuel Rodriguez Iglesias, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 55 Calle Font Martelo W, Humacao, PR 00791 Phone: 787-852-1770 | |
Dr. Francisco Javier Cruz Rodriguez, MD General Practice Medicare: Medicare Enrolled Practice Location: 300 Sector Cuesta Los Jobos, Humacao, PR 00791 Phone: 787-852-0505 |